Veeva Systems (VEEV) valuation
Veeva Systems P/E ratio history
Veeva Systems trades at 51.2 times its earnings over the last twelve months and 32.1 times the earnings analysts expect over the next twelve. At its last 10 fiscal year ends its P/E ranged from 37.5 (year to Jan 2026) to 117.1 (year to Jan 2021), with a median of 69.3.
| Fiscal year ended | Price | EPS | P/E | Forward P/E |
|---|---|---|---|---|
| Jan 31, 2026 | $203.92 | $5.44 | 37.5 | 24.2 |
| Jan 31, 2025 | $233.26 | $4.32 | 54.0 | 34.4 |
| Jan 31, 2024 | $207.41 | $3.22 | 64.4 | 38.6 |
| Jan 31, 2023 | $170.55 | $3.00 | 56.9 | 38.9 |
| Jan 31, 2022 | $236.54 | $2.63 | 89.9 | 61.1 |
| Jan 31, 2021 | $276.44 | $2.36 | 117.1 | — |
| Jan 31, 2020 | $146.61 | $1.91 | 76.8 | — |
| Jan 31, 2019 | $109.06 | $1.47 | 74.2 | — |
| Jan 31, 2018 | $62.86 | $0.98 | 64.1 | — |
| Jan 31, 2017 | $42.33 | $0.48 | 88.2 | — |
n/m: not meaningful (a loss, or earnings close to zero). The daily P/E line is a chart indicator in the app.
Veeva Systems valuation against its peers
| Company | Market value | P/E | Forward P/E | Price / sales |
|---|---|---|---|---|
| Veeva SystemsVEEV | $50.8B | 51.2 | 32.1 | 14.7 |
| HumanaHUM | $49.8B | 39.1 | 31.6 | 0.3 |
| Cardinal HealthCAH | $58.7B | 34.6 | — | 0.2 |
| CenteneCNC | $33.8B | 22.7 | 12.6 | 0.2 |
| CignaCI | $78.9B | 12.3 | 9.3 | 0.3 |
| LabcorpLH | $29.6B | 29.7 | 18.6 | 2.1 |
| Elevance HealthELV | $91.2B | 17.8 | 14.0 | 0.5 |
| Quest DiagnosticsDGX | $27.8B | 25.1 | 21.3 | 2.4 |
| HCA HealthcareHCA | $102B | 15.7 | 15.3 | 1.3 |
| Peer median | 23.9 | 15.3 | 0.4 |
Reading these multiples
The P/E divides the share price by earnings per share over the last twelve months; the forward P/E divides it by the earnings analysts expect over the next twelve. Price to sales compares the company's market value with its revenue over the last twelve months. A multiple reads differently from one industry to the next, so the peer group above is the fairer comparison.
See also: VEEV financials · VEEV returns
No forecast, no recommendation. This page describes Veeva Systems from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.